Clinical Trials Sponsored by AbbVie
Total 1217 results
-
Johns Hopkins UniversityAbbVieRecruitingHepatitis C Virus Infection, Response to Therapy ofUnited States, Canada
-
AbbVieIronwood Pharmaceuticals, Inc.Active, not recruitingIrritable Bowel Syndrome With Constipation | Functional ConstipationUnited States, Canada, Israel, Netherlands
-
AbbVieGedeon Richter Plc.Active, not recruitingHealthy Participants | Generalized Anxiety Disorder (GAD)United States
-
University of WashingtonAbbVieSuspendedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Refractory Mixed Phenotype Acute Leukemia | Myeloid Neoplasm | Acute Biphenotypic Leukemia | Refractory Acute Biphenotypic Leukemia | Relapsed Acute Myeloid Leukemia | Mixed Phenotype Acute Leukemia | Relapsed Acute Biphenotypic Leukemia | Relapsed... and other conditionsUnited States
-
Bristol-Myers SquibbAbbVieActive, not recruitingMultiple MyelomaUnited States, Canada, Australia, Poland, Italy, Belgium, Spain, Japan, Greece, Hungary, Romania, Turkey, United Kingdom
-
Technische Universität DresdenAbbVieActive, not recruitingRelapsed Adult AML | Refractory AMLGermany
-
Zuyderland Medisch CentrumAbbVieActive, not recruitingParkinson DiseaseNetherlands
-
AbbVieIdera Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors CancerUnited States, France, Germany, Israel, Netherlands, Spain
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom
-
AbbVieGenentech, Inc.; AmgenTerminatedAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States, Australia, Germany
-
University of WashingtonAbbVieNo longer availableTriple-Negative Breast Cancer | Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic MutationUnited States
-
AbbVieIST GmbH, GermanyCompleted
-
Hoffmann-La RocheAbbVieCompletedFollicular LymphomaUnited States, Italy, Canada, Australia, Belgium, United Kingdom, Germany, France
-
Landon Pediatric FoundationAbbVieCompletedMedication Adherence | Cystic FibrosisUnited States
-
AbbVieIST GmbH, GermanyCompleted
-
University of PennsylvaniaAbbVieCompletedCardiovascular Disease | PsoriasisUnited States
-
University of ChicagoAbbVieRecruitingAcute Myeloid LeukemiaUnited States
-
Trishula Therapeutics, Inc.AbbVieCompletedSolid Tumor, AdultUnited States, Korea, Republic of
-
Bristol-Myers SquibbAbbVieNo longer available
-
Hannover Medical SchoolAbbVieTerminatedHepatitis C, ChronicGermany
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaCanada, United States, Israel, Czechia, Switzerland, Greece, Denmark, Portugal, Italy, Germany, Austria, Norway, Puerto Rico, Spain, Sweden, Turkey
-
Ohio State UniversityAbbVieActive, not recruiting
-
Bristol-Myers SquibbAbbVieCompletedLymphoma | Multiple MyelomaUnited States, Belgium, France, Germany, Italy, Japan, United Kingdom, Australia, Poland, Puerto Rico, Canada, Denmark, Hungary, Israel, Spain, Czechia, Ireland, Austria, Switzerland, Greece, Turkey, Romania, United Arab Emirates
-
Massachusetts General HospitalAbbVieCompletedChronic Kidney Disease | Chronic Hepatitis CUnited States
-
University of LeedsAbbVieUnknownRheumatoid Arthritis | Inflammatory ArthritisUnited Kingdom
-
Virginia Commonwealth UniversityAbbVieWithdrawnRelapsed Small Cell Lung Cancer | Refractory Small Cell Lung Carcinoma
-
AbbVieBristol-Myers SquibbTerminatedSmall Cell Lung CancerUnited States, France, Germany, Italy, Spain
-
Bristol-Myers SquibbAbbVieCompletedSmoldering Multiple MyelomaUnited States
-
University of HelsinkiAbbVieUnknownAnkylosing SpondyloarthritisFinland
-
University of SydneyAbbVieNo longer available
-
AbbVie (prior sponsor, Abbott)Cato Research; JSS Medical Research Inc.Completed
-
AbbVie (prior sponsor, Abbott)Assign Data Management and Biostatistics GmbHCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease Stage V | Cardiac MorbidityAustria
-
University of New MexicoAbbVieNot yet recruitingGlabellar Frown Lines | Adjuvant Zinc May Increase the Efficacy of Botulinum Toxin | Zinc Supplementation for Botulinum Toxin Treatment of the Forehead | Botulinum Toxin, Cosmetic | Adjuvant Oral Zinc and Botulinum Toxin
-
GLSMED Learning Health S.A.AbbVieRecruitingCrohn DiseaseSpain, Italy, Denmark, Belgium, Cyprus, Czechia, France, Malta, Portugal, Romania, United Kingdom
-
Dana-Farber Cancer InstituteAbbVieRecruitingB-Cell Lymphoma | B-cell Acute Lymphoblastic Leukemia | ALLUnited States
-
Calico Life Sciences LLCAbbVieRecruitingAdvanced Solid Tumor CancerUnited States, Korea, Republic of, Spain, Israel, Japan, France
-
Jacobio Pharmaceuticals Co., Ltd.AbbVieRecruitingNon Small Cell Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell CarcinomaChina
-
Dana-Farber Cancer InstituteAbbVieRecruiting
-
AbbVieJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, Denmark, France, Germany, Japan
-
Fondazione Italiana Linfomi - ETSAbbVieActive, not recruitingRituximab, Bendamustine and Cytarabine Followed by Venetoclax in High Risk Elderly Patients With MCLLymphoma, Mantle-CellItaly
-
M.D. Anderson Cancer CenterAbbVieTerminatedAdvanced CancersUnited States
-
University Hospital "Sestre Milosrdnice"AbbVieActive, not recruitingDry Eye | Ocular Surface DiseaseCroatia
-
Calico Life Sciences LLCAbbVieCompletedHealthyUnited States
-
Bristol-Myers SquibbAbbVie; CelgeneCompletedMultiple MyelomaUnited States, Germany, Italy, Greece, Netherlands, Australia, Spain, Poland, Canada, France, Japan
-
AbbVieSumitomo Pharma Oncology, Inc.CompletedAcute Myeloid Leukemia (AML)United States, Germany, United Kingdom
-
HaEmek Medical Center, IsraelAbbVieCompleted
-
AbbVie (prior sponsor, Abbott)Cato Research; JSS Medical Research Inc.Completed
-
AbbVie (prior sponsor, Abbott)CMX Research; JSS Medical Research Inc.Completed
-
Groupe Francophone des MyelodysplasiesAbbVieRecruitingChronic Myeloid LeukemiaFrance